(Date:12/1/2008)...lements can also trigger acute organ failure, stud...s) -- Antibiotics are the single largest class of ...injury (DILI), researchers say. , The condition...iver failure in the United States and is the most ..., DILI is caused by a wide range of prescription ...
(Date:12/1/2008)...ps up successful disaster relief campaign , ,...he American Red Cross is asking people across the ...lion in 30 days. This holiday season push will put...Red Cross Campaign for Disaster Relief. Already, t...s launch in September, and the Red Cross hopes to ...
(Date:12/1/2008)... Today, more than 740 c...ople die each day due to HIV/AIDS. , , D...d outreach to help people worldwide understand the...S Day 2008 is You Can Make a Difference and th...her to talk about HIV as well as helping dispel th...
(Date:12/1/2008)...wswire-FirstCall/ -- SpectraScience, Inc.,(OTC Bu...ice company, today,announced that it has been awa...tem for Tissue Diagnosis. , Jim Hitchin, Spectr...nt to,the Company,s optical biopsy technology bec...e surveillance, characterization, diagnosis and tr...
Breaking Medicine News(10 mins):Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2(Date:11/28/2008)...Nov. 28 Eli Lilly and Co...al New Drug Application (sNDA) from,the U.S. Food...loxetine HCl),for the management of chronic pain....irst half of 2009, adding data from a recently com...ain of the knee. , The decision does not af...
(Date:11/26/2008)... to 406 Subjects , , FRANKLIN, Mass., Nov. ... Bulletin Board: PLCSF) announced today that it ha...ug Administration (FDA) for its U.S. pivotal trial...Guard System(TM) and associated therapy in the pr... , The FDA also approved PLC,s request to ex...
(Date:11/25/2008)...CISCO, Calif., Nov. 25 Proteolix, ...f novel therapeutics that target,protein degradat...day,announced that data from two ongoing Phase 2 ...a will be presented at the upcoming 50th Annual Me.... Carfilzomib is the first in a new class,of spe...
(Date:11/25/2008).... 25 CardioVascular,Bio...ounced today that it has,dosed the first patient ...I,clinical trial to treat patients with severe co... the treatment of CORonary heart Disease) trial wi...-controlled doses in approximately 120,patients w...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 1Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 2Circulating tumor cells can reveal genetic signature of dangerous lung cancers 23209 3Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 23205 1Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 23205 2SpectraCell Laboratories Now Measures Vitamin C 6365 1SpectraCell Laboratories Now Measures Vitamin C 6365 2Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 1Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 2Circulating Tumor Cells Reveal Insights Into Lung Cancers 23201 3..., Calif.--(BUSINESS WIRE)--Mar 14, 2007 - Research...say they are puzzled by,findings from their new st...ously showed promise in treating a behavioral diso... a sustained benefit,for the patients who took it....ribed,antidepressant sold under the brand name Lex...
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: